Daptomycin Versus Vancomycin Plus Gentamicin for Treatment of Bacteraemia and Endocarditis Due to Staphylococcus aureus: Subset Analysis of Patients Infected with Methicillin-resistant Isolates

DSpace/Manakin Repository

Daptomycin Versus Vancomycin Plus Gentamicin for Treatment of Bacteraemia and Endocarditis Due to Staphylococcus aureus: Subset Analysis of Patients Infected with Methicillin-resistant Isolates

Show simple item record

dc.contributor.author Rehm, Susan J.
dc.contributor.author Boucher, Helen
dc.contributor.author Levine, Donald
dc.contributor.author Campion, Marilyn
dc.contributor.author Vigliani, Gloria A.
dc.contributor.author Corey, G.Ralph
dc.contributor.author Abrutyn, Elias
dc.contributor.author Eisenstein, Barry
dc.date.accessioned 2012-03-23T15:34:17Z
dc.date.issued 2008
dc.identifier.citation Rehm, Susan J., Helen Boucher, Donald Levine, Marilyn Campion, Barry I. Eisenstein, Gloria A. Vigliani, G.Ralph Corey, and Elias Abrutyn. 2008. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. Journal of Antimicrobial Chemotherapy 62(6): 1413-1421. en_US
dc.identifier.issn 0305-7453 en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8438178
dc.description.abstract Objectives: In a prospective, randomized trial, daptomycin was non-inferior to standard therapy for Staphylococcus aureus bacteraemia and right-sided endocarditis. Since rates of infection due to methicillin-resistant S. aureus (MRSA) infection are increasing and treatment outcomes for bacteraemia caused by MRSA are generally worse than those observed with methicillin-susceptible S. aureus bacteraemia, clinical characteristics and treatment results in the trial’s pre-specified subset of patients with MRSA were analysed. Methods: Clinical characteristics and outcomes of patients receiving daptomycin were compared with those receiving vancomycin plus low-dose gentamicin. Success was defined as clinical improvement with clearance of bacteraemia among patients who completed adequate therapy, received no potentially effective non-study antibiotics and had negative blood cultures 6 weeks after end of therapy. Results: Twenty of the 45 (44.4%) daptomycin patients and 14 of the 43 (32.6%) vancomycin/gentamicin patients were successfully treated (difference 11.9%; confidence interval −8.3 to 32.1). Success rates for daptomycin versus vancomycin/gentamicin were 45% versus 27% in complicated bacteraemia, 60% versus 45% in uncomplicated bacteraemia and 50% versus 50% in right-sided MRSA endocarditis. Cure rates in patients with septic emboli and in patients who received pre-enrolment vancomycin were similar between treatment groups. However, in both treatment groups, success rates were lower in the elderly (≥75 years). Persisting or relapsing bacteraemia occurred in 27% of daptomycin and 21% of vancomycin/gentamicin patients; among these patients, MICs of ≥2 mg/L occurred in five daptomycin and four vancomycin/gentamicin patients. The clinical course of several patients may have been influenced by lack of surgical intervention. Conclusions: Daptomycin was an effective alternative to vancomycin/gentamicin for MRSA bacteraemia or right-sided endocarditis. en_US
dc.language.iso en_US en_US
dc.publisher Oxford University Press en_US
dc.relation.isversionof doi:10.1093/jac/dkn372 en_US
dc.relation.hasversion http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583068/pdf/ en_US
dash.license LAA
dc.subject MRSA en_US
dc.subject endovascular infections en_US
dc.subject bloodstream infections en_US
dc.subject combination therapy en_US
dc.subject clinical trial en_US
dc.title Daptomycin Versus Vancomycin Plus Gentamicin for Treatment of Bacteraemia and Endocarditis Due to Staphylococcus aureus: Subset Analysis of Patients Infected with Methicillin-resistant Isolates en_US
dc.type Journal Article en_US
dc.description.version Version of Record en_US
dc.relation.journal Journal of Antimicrobial Chemotherapy en_US
dash.depositing.author Eisenstein, Barry
dc.date.available 2012-03-23T15:34:17Z
dash.affiliation.other HMS^Medicine- Beth Israel-Deaconess en_US

Files in this item

Files Size Format View
2583068.pdf 181.1Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters